Medriaxone 250mg/125mg Injection
Marketer
Medrica Pharmaceuticals Private Limited
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Medriaxone 250mg/125mg Injection
Axomed 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial growth and propagation. Administration must be strictly under medical guidance; adhere to all scheduled doses, completing the prescribed course regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek emergency care for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While typically not impairing driving ability, refrain from driving if experiencing somnolence or dizziness. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your doctor may order tests to monitor treatment response.
Uses of Medriaxone 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Medriaxone 250mg/125mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Medriaxone 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Medriaxone 250mg/125mg Injection:
This medication will be administered by your physician or their qualified assistant. Self-medication is strictly prohibited.
How Medriaxone 250mg/125mg Injection works:
Ceftriaxone/Sulbactam 250mg/125mg Injection (Medriaxone) combines a cephalosporin antibiotic, Ceftriaxone, with a beta-lactamase inhibitor, Sulbactam. Ceftriaxone's mechanism of action disrupts bacterial cell wall synthesis, hindering their ability to multiply. Sulbactam's role is to counter bacterial resistance mechanisms, thereby bolstering Ceftriaxone's antimicrobial effect.
SAFETY ADVICE
AlcoholSAFE
Medriaxone 250mg/125mg Injection shows no adverse interactions with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Medriaxone (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Medriaxone 250mg/125mg Injection necessitates prudence while breastfeeding. Mothers should temporarily discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Medriaxone 250mg/125mg Injection can potentially lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Medriaxone 250mg/125mg Injection use in individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Patients with severe hepatic impairment should receive Medriaxone 250mg/125mg Injection cautiously, potentially requiring dosage modification. Mild to moderate liver dysfunction does not necessitate Medriaxone 250mg/125mg Injection dose alteration; however, physician consultation is advised.
What if you forget to take Medriaxone 250mg/125mg Injection :
Should you forget a scheduled dose of Medriaxone 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Medriaxone 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently